The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on D34+/CD38+ and CD34+/CD38- AML Progenitor Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|1|51-63

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.1, 2012-01, pp. : 51-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SSEA-4+ CD34- Cells in the Adult Human Heart Show the Molecular Characteristics of a Novel Cardiomyocyte Progenitor Population

By  

Cells Tissues Organs, Vol. 199, Iss. 2-3, 2014-08 ,pp. : 103-116

Karger

Access to resources Recommend Favorite

Identification of Thiazoloquin(az)olin(on)es Derivatives as CD38 Inhibitors Through 3D-QSAR and Molecular Docking Simulations

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 2, 2016-12 ,pp. : 175-185

Bentham Science Publishers

Access to resources Recommend Favorite

AMD 3100 induces rapid mobilisation of CD34+ cells

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

New SRC/ABL inhibitors for chronic myeloid leukemia therapy show selectivity for T315I ABL mutant CD34+ cells

By Santucci Maria   Mancini Manuela   Corradi Valentina   lacobucci Ilaria   Martinelli Giovanni   Botta Maurizio   Schenone Silvia  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 876-878

Springer Publishing Company

Access to resources Recommend Favorite

The Identification of New CD38 Inhibitors by Combined Structure and Ligand Based Virtual Screening Approaches of ZINC Database

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 6, 2018-04 ,pp. : 654-660

Bentham Science Publishers

Access to resources Recommend Favorite